Inhibitory ITAMs as novel regulators of immunity
暂无分享,去创建一个
M. Benhamou | R. Monteiro | P. Launay | U. Blank | Ulrich Blank | Pierre Launay | Marc Benhamou | Renato C. Monteiro
[1] J. Fehr,et al. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. , 1982, The New England journal of medicine.
[2] B. Evavold,et al. Cutting Edge: Dependence of TCR Antagonism on Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Activity1 , 2003, The Journal of Immunology.
[3] H. Grey,et al. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor , 1992, Cell.
[4] K. Coggeshall,et al. How do inhibitory phosphatases work? , 2002, Molecular immunology.
[5] W. Hong,et al. VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways. , 2008, Blood.
[6] Wei Cao,et al. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production , 2006 .
[7] K. Rajewsky,et al. Interference with Immunoglobulin (Ig)α Immunoreceptor Tyrosine–Based Activation Motif (Itam) Phosphorylation Modulates or Blocks B Cell Development, Depending on the Availability of an Igβ Cytoplasmic Tail , 2001, The Journal of experimental medicine.
[8] D. Carbone,et al. Regulation of mast cell survival by IgE. , 2001, Immunity.
[9] P. Allen,et al. Partially Phosphorylated T Cell Receptor ζ Molecules Can Inhibit T Cell Activation , 1999, The Journal of experimental medicine.
[10] L. Lanier,et al. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Monteiro,et al. Autoimmunity in IgA Deficiency: Revisiting the Role of IgA as a Silent Housekeeper , 2008, Journal of Clinical Immunology.
[12] M. Eibl,et al. Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. , 1994, Blood.
[13] K. Rajewsky,et al. Ig-alpha cytoplasmic truncation renders immature B cells more sensitive to antigen contact. , 1999, Immunity.
[14] D. Thorley-Lawson,et al. EBV persistence in memory B cells in vivo. , 1998, Immunity.
[15] J. Russo,et al. MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture , 2005, The Journal of experimental medicine.
[16] J. Wilton. Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes. , 1978, Clinical and experimental immunology.
[17] W. Fridman,et al. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. , 1993, Lancet.
[18] J. Swanson,et al. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages , 1996, The Journal of cell biology.
[19] M. Colonna,et al. Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.
[20] J. Mestecky,et al. IgA antibody as a non-inflammatory regulator of immunity. , 1997, Biochemical Society transactions.
[21] Toshiaki Kawakami,et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] Wei Cao,et al. Plasmacytoid dendritic cell–specific receptor ILT7–FcɛRIγ inhibits Toll-like receptor–induced interferon production , 2006, The Journal of experimental medicine.
[23] J. Gern. Antiinflammatory Activity of IVIG Mediated through the Inhibitory FC Receptor , 2002 .
[24] S. Latour,et al. Negative regulation of immunoreceptor signaling. , 2002, Annual review of immunology.
[25] J. Monroe,et al. Viral immunoreceptor-associated tyrosine-based activation motifs: potential players in oncogenesis. , 2006, Future oncology.
[26] M. Huber,et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. , 2001, Immunity.
[27] D. Underhill,et al. The many faces of ITAMs. , 2007, Trends in immunology.
[28] J. Woof,et al. Function of immunoglobulin A in immunity , 2000, Gut.
[29] R. Mariuzza,et al. Cis interactions of immunoreceptors with MHC and non-MHC ligands , 2008, Nature Reviews Immunology.
[30] Ralph,et al. Suppression of leukocyte chemotaxis by human IgA myeloma components , 1976, The Journal of experimental medicine.
[31] M. Hatakeyama. Oncogenic mechanisms of the Helicobacter pylori CagA protein , 2004, Nature Reviews Cancer.
[32] M. Daëron,et al. Negative signaling in Fc receptor complexes. , 2006, Advances in immunology.
[33] L. Lanier,et al. Inhibition of Immune Responses by ITAM-Bearing Receptors , 2006, Science's STKE.
[34] K. Rajewsky,et al. Ig-α Cytoplasmic Truncation Renders Immature B Cells More Sensitive to Antigen Contact , 1999 .
[35] C. Janeway,et al. Cross-antagonism of a T cell clone expressing two distinct T cell receptors. , 1999, Immunity.
[36] L. Lanier,et al. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. , 1998, Journal of immunology.
[37] C. Sautès-Fridman,et al. Activation of Human Peripheral IgM+ B Cells Is Transiently Inhibited by BCR-Independent Aggregation of FcγRIIB1 , 2008, The Journal of Immunology.
[38] C. Ra,et al. The FcϵRIβ Immunoreceptor Tyrosine-based Activation Motif Exerts Inhibitory Control on MAPK and IκB Kinase Phosphorylation and Mast Cell Cytokine Production* , 2004, Journal of Biological Chemistry.
[39] P. Allen,et al. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. , 1991, Science.
[40] I. Moura,et al. Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation: Dual Role of FcRγ ITAM , 2005 .
[41] M. Russell,et al. Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL‐8‐stimulated cells , 1995, Journal of leukocyte biology.
[42] M. Colonna,et al. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. , 2006, Blood.
[43] M. Benhamou,et al. Inhibitory ITAMs: a matter of life and death. , 2008, Trends in immunology.
[44] M. Colonna,et al. Activating and inhibitory functions of DAP12 , 2007, Nature Reviews Immunology.
[45] C. Lay,et al. The Interaction of FcαRI with IgA and Its Implications for Ligand Binding by Immunoreceptors of the Leukocyte Receptor Cluster1 , 2001, The Journal of Immunology.
[46] D. Thorley-Lawson,et al. Epstein-Barr virus: exploiting the immune system , 2001, Nature Reviews Immunology.
[47] R. Monteiro,et al. Alternative Endocytic Pathway for Immunoglobulin A Fc Receptors (CD89) Depends on the Lack of FcRγ Association and Protects against Degradation of Bound Ligand* , 1999, The Journal of Biological Chemistry.
[48] K. Sakaguchi,et al. Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor. , 1997, Journal of immunology.
[49] N. Mackman,et al. The Phosphatidylinositol 3-Kinase-Akt Pathway Limits Lipopolysaccharide Activation of Signaling Pathways and Expression of Inflammatory Mediators in Human Monocytic Cells* , 2002, The Journal of Biological Chemistry.
[50] M. Colonna,et al. A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha. , 2004, Blood.
[51] P. Allen,et al. Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. , 1998, Science.
[52] J. Freedman,et al. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. , 2006, Nature medicine.
[53] W. Fridman,et al. Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura , 1993, The Lancet.
[54] T. Kawakami,et al. IgA Fc receptor (CD89) activation enables coupling to syk and Btk tyrosine kinase pathways: differential signaling after IFN‐γ or phorbol ester stimulation , 1998, Journal of leukocyte biology.
[55] J. Billingsley,et al. Molecular Dissection of the FcRβ Signaling Amplifier* , 2004, Journal of Biological Chemistry.
[56] F. Vrtovsnik,et al. Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation. , 2008, Journal of immunology.
[57] L. Marnell,et al. C-Reactive Protein-Mediated Suppression of Nephrotoxic Nephritis: Role of Macrophages, Complement, and Fcγ Receptors1 , 2007, The Journal of Immunology.
[58] R. Medzhitov,et al. Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling , 2006, Cell.
[59] Paul M. Allen,et al. Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.
[60] S. Koyasu,et al. PI3K and negative regulation of TLR signaling. , 2003, Trends in immunology.
[61] R. Monteiro,et al. IgA Fc receptor I signals apoptosis through the FcRgamma ITAM and affects tumor growth. , 2007, Blood.
[62] J. Monroe. ITAM-mediated tonic signalling through pre-BCR and BCR complexes , 2006, Nature Reviews Immunology.
[63] M. Tsai,et al. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. , 2004, Immunity.
[64] M. Kerr,et al. The structure and function of human IgA. , 1990, The Biochemical journal.
[65] Bernhard Hemmer,et al. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways , 2003, Nature Immunology.
[66] A. Hirt,et al. HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD , 1981, The Lancet.
[67] T. Jardetzky,et al. The IgA receptor complex: a two-for-one deal , 2003, Nature Structural Biology.
[68] F. Vrtovsnik,et al. Fcα receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcRγ adaptor , 2007 .
[69] J. Ravetch,et al. Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.
[70] R. Monteiro,et al. Fcα Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease) , 2000, The Journal of experimental medicine.
[71] D. Choquet,et al. The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein‐Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. , 1993, The EMBO journal.
[72] B. Corthésy. Roundtrip Ticket for Secretory IgA: Role in Mucosal Homeostasis?1 , 2007, The Journal of Immunology.
[73] J. Trowsdale,et al. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling , 2006, European journal of immunology.
[74] H. Schwarz,et al. Immunomodulatory properties of human serum immunoglobulin A: anti‐inflammatory and pro‐inflammatory activities in human monocytes and peripheral blood mononuclear cells , 2005, Clinical and experimental immunology.
[75] I. Moura,et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. , 2005, Immunity.
[76] I. Velasco,et al. CD16 promotes Escherichia coli sepsis through an FcRγ inhibitory pathway that prevents phagocytosis and facilitates inflammation , 2007, Nature Medicine.
[77] K. M. Bendt,et al. Epstein-Barr Virus LMP2A Transforms Epithelial Cells, Inhibits Cell Differentiation, and Activates Akt , 2000, Journal of Virology.
[78] R. Williams,et al. Suppression of human PMN bactericidal activity by human IgA paraproteins. , 1978, Cellular immunology.
[79] H. Perkins. IgA deficiency. , 1984, Immunohematology.
[80] R. Clynes. Protective mechanisms of IVIG. , 2007, Current opinion in immunology.
[81] R. Monteiro,et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. , 2000, The Journal of experimental medicine.
[82] B. Neel,et al. FcγRIII-Dependent Inhibition of Interferon-γ Responses Mediates Suppressive Effects of Intravenous Immune Globulin , 2007 .
[83] P. Allen,et al. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells , 1993, Nature.
[84] H. Metzger,et al. An unusual mechanism for ligand antagonism. , 1998, Science.
[85] C. Marsh,et al. The Protein-tyrosine Phosphatase SHP-1 Associates with the Phosphorylated Immunoreceptor Tyrosine-based Activation Motif of FcγRIIa to Modulate Signaling Events in Myeloid Cells* , 2003, Journal of Biological Chemistry.
[86] J. Cobb,et al. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis , 2005, The Journal of experimental medicine.
[87] L. Marnell,et al. C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors. , 2007, Journal of immunology.
[88] T. Lund. Faculty Opinions recommendation of Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. , 2008 .
[89] T. Asano,et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs , 2002, Nature Immunology.
[90] M. Reth. Antigen receptor tail clue , 1989, Nature.
[91] T. Kurosaki,et al. SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis. , 1999, Immunity.
[92] T. Kurosaki,et al. SHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis , 1999 .
[93] C. Abram,et al. The Expanding Role for ITAM-Based Signaling Pathways in Immune Cells , 2007, Science's STKE.
[94] B. Evavold,et al. Cutting edge: dueling TCRs: peptide antagonism of CD4+ T cells with dual antigen specificities. , 1998, Journal of immunology.
[95] E. Kieff,et al. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. , 1995, Immunity.
[96] Lionel B Ivashkiv,et al. Cross-regulation of signaling by ITAM-associated receptors , 2009, Nature Immunology.
[97] L. Lanier,et al. Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP121 , 2006, The Journal of Immunology.
[98] M. Colonna,et al. Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. , 2005, Blood.
[99] G. Cheng,et al. LILRA2 Activation Inhibits Dendritic Cell Differentiation and Antigen Presentation to T Cells1 , 2007, The Journal of Immunology.
[100] A. Mócsai,et al. ITAM-based signaling beyond the adaptive immune response. , 2006, Immunology letters.
[101] J. Ravetch,et al. Identification of a receptor required for the anti-inflammatory activity of IVIG , 2008, Proceedings of the National Academy of Sciences.
[102] F. Vrtovsnik,et al. Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor. , 2007, European Journal of Immunology.
[103] J. Ravetch,et al. Inhibitory pathways triggered by ITIM-containing receptors. , 1999, Advances in immunology.
[104] S. Kaveri,et al. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. , 2003, Blood.
[105] F. Sutterwala,et al. Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type I , 1998, The Journal of experimental medicine.
[106] R. Küppers,et al. CD303 (BDCA‐2) signals in plasmacytoid dendritic cells via a BCR‐like signalosome involving Syk, Slp65 and PLCγ2 , 2007, European journal of immunology.
[107] L. Lanier,et al. DAP12: an adapter protein with dual functionality , 2006, Immunological reviews.
[108] L. Lanier. Viral immunoreceptor tyrosine-based activation motif (ITAM)-mediated signaling in cell transformation and cancer. , 2006, Trends in cell biology.
[109] Eric Vivier,et al. Natural Killer Cell Signaling Pathways , 2004, Science.
[110] D. V. Van Epps,et al. Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins , 1981, Infection and immunity.
[111] C. Ra,et al. The FcepsilonRIbeta immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production. , 2004, The Journal of biological chemistry.
[112] Eric M. Billings,et al. F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins , 2003, Nature Medicine.
[113] J. Ravetch,et al. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. , 2001, Science.
[114] L. Piccio,et al. Cutting Edge: TREM-2 Attenuates Macrophage Activation1 , 2006, The Journal of Immunology.
[115] L. Lanier,et al. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12 , 2005, Nature Immunology.
[116] R. Monteiro,et al. IgA Fc receptors. , 2003, Annual review of immunology.
[117] J. Ravetch,et al. Anti-inflammatory actions of intravenous immunoglobulin. , 2008, Annual review of immunology.